TrialInternational journal of clinical oncology2025

Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan.

Daisuke Kotani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.